Society guideline links: COVID-19 – Allergy and immunology care

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)

Allergic reactions to COVID-19 vaccination

●(See "Society guideline links: COVID-19 – General guidelines for vaccination", section on 'Allergic reactions'.)

Office and clinic preparedness

●International

•World Allergy Organization (WAO): Preparing your office for the COVID-19 pandemic (2020)

●Canada

•COVID-19: Pandemic contingency planning for the allergy and immunology clinic (2020)

●United States

•COVID-19: Pandemic contingency planning for the allergy and immunology clinic (2020)

•European Academy of Allergy and Clinical Immunology (EAACI)/Allergic Rhinitis and its Impact on Asthma (ARIA): COVID‐19 pandemic – Position paper on practical considerations on the organization of an allergy clinic (2020)

●Europe

•European Academy of Allergy and Clinical Immunology (EAACI)/Allergic Rhinitis and its Impact on Asthma (ARIA): COVID‐19 pandemic – Position paper on practical considerations on the organization of an allergy clinic (2020)

Patients with allergies, allergic diseases, and immunodeficiency

●Canada

•Canadian Society of Allergy and Clinical Immunology (CSACI): Management of allergic rhinitis during COVID-19 pandemic (2020)

●United States

•Allergic Rhinitis and its Impact on Asthma (ARIA)-European Academy of Allergy and Clinical Immunology (EAACI): Statement on intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients (2020)

•ARIA-EAACI: Statement on the handling of allergen immunotherapy in the COVID‐19 pandemic (2020)

•American College of Allergy, Asthma, and Immunology (ACAAI): Statement on COVID-19 and asthma, allergy, and immune deficiency patients (2020)

●Europe

•European Society for Blood and Marrow Transplantation (EBMT): Guidelines and recommendations for hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19 (2021)

•Allergic Rhinitis and its Impact on Asthma (ARIA)-European Academy of Allergy and Clinical Immunology (EAACI): Statement on intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients (2020)

•ARIA-EAACI: Statement on the handling of allergen immunotherapy in the COVID‐19 pandemic (2020)

•EAACI: Position paper on diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19 (2020)

•EAACI: Statement on considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic (2020)

•EAACI: Statement for managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic (2020)

•EAACI: Position paper for the management of patients with chronic rhinosinusitis during the COVID‐19 pandemic (2020)

•European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA): A statement on allergic respiratory disease care in the COVID-19 era (2020)

Resources for patients — The following links provide resources about COVID-19 for non-clinicians. These resources come from select society and government-sponsored guidelines from several countries and regions around the world.

●[International] Global Initiative for Asthma (GINA): Recommendations for inhaled asthma controller medications

●[International] World Allergy Organization (WAO): Allergic patients during COVID-19 pandemic

●[Canada] Canadian Society of Allergy and Clinical Immunology (CSACI): COVID-19 FAQ's

●[United States] American Academy of Allergy, Asthma, and Clinical Immunology (AAAAI): COVID-19 resources

●[United States] Immune Deficiency Foundation (IDF): COVID-19

●[Europe] European Academy of Allergy and Clinical Immunology (EAACI): Coronavirus infection and allergies – What do we know?

●[United Kingdom] British Society for Allergy and Clinical Immunology (BSACI): Coronavirus and allergies frequently asked questions

●[Australia–New Zealand] Australian Society of Clinical Immunology and Allergy (ASCIA): COVID-19

UpToDate also offers "The Basics" patient education pieces, which are written by the doctors and editors at UpToDate. These are written in plain language, at the 5^th to 6^th grade reading level, and answer the main questions a person is likely to have. (See "Patient education: COVID-19 overview (The Basics)" and "Patient education: COVID-19 and children (The Basics)" and "Patient education: COVID-19 and pregnancy (The Basics)" and "Patient education: COVID-19 vaccines (The Basics)".)